Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of Chinese medicine Shensong Yangxin
capsule for the chronic cardiac dysfunction complicated with ventricular premature beats.
Phase:
Phase 4
Details
Lead Sponsor:
Cong-xin Huang
Collaborators:
Chinese Academy of Medical Sciences, Fuwai Hospital Fudan University Nanjing Medical University Shanghai Changzheng Hospital Third Military Medical University